Clinical Trial Update: 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003) [Phase 2]

View source ↗

Summary

Phase 2 trial of No-Rofecoxib plus aspirin for arthritis patients undergoing endoscopy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Aspirin (Aspirin)
• No-Rofecoxib

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid, Osteoarthritis | Phase 2 | Status: TERMINATED